People

Inhaler monitoring company Adherium has named former Vectura CEO James Ward-Lilley as a director and Chairman of the Board after the recent death of Thomas Lynch, who had been Chairman since 2016. The company also promoted Mike Motion from Chief Commercial Officer, a position he had held since November 2019, to Chief Operating Officer. Prior to joining Vectura as … [Read more...] about Adherium appoints James Ward-Lilley as Chairman of the Board following the death of Thomas Lynch

Finnish nanoparticle engineering company Nanoform has announced the beginning of a year-long process that will conclude with Miguel Calado succeeding Rabbe Klemets as Chairman of the Board. Klemets will take on an advisory role. Calado is currently Vice Chairman of the Board; he will be succeeded in that role by non-executive board member, Mads Laustsen. Prior to … [Read more...] about Nanoform appoints Miguel Calado as Chairman of the Board

Aerosol testing specialist Proveris Scientific has announced two new hires: Lee Dalton has joined Proveris as Director of Sales for North America, and Juan Osvaldo Moliere Velez, a mechanical engineer, has joined the company's technical service team. Dalton was most recently Sales Manager, Applied Sciences for Swedish intrument company Biotage AB. He has … [Read more...] about Proveris Scientific announces new hires

Vectura has announced the appointment of Mark Bridgewater as Chief Commercial Officer, a position the company said it has created as it "continues with its strategy to become a leading inhalation specialist in the pharmaceutical services space." In February 2020, the company announced the appointment of Sharon Johnson as Executive VP for Delivery Management, another … [Read more...] about Mark Bridgewater joins Vectura as Chief Commercial Officer

Sumitovant Biopharma subsidiary Altavant Sciences has announced the appointment of  Howard M. Lazarus as Chief Medical Officer, a newly created position. Lazarus was most recently Medical Expert/Executive Director in Clinical Development and Medical Affairs at Boehringer Ingelheim and was previously Director, Medical Affairs for Pulmonary Hypertension at Gilead … [Read more...] about Altavant Sciences appoints Howard M. Lazarus as Chief Medical Officer

Nanopharm CEO Jag Shur has announced the addition of three new members of the company's management team in a LinkedIn post. The new hires include two OINDP experts: Dave Farrow, who joins the company as Director of Operations, and Chris Vernall as Director of Business Development. Farrow was most recently Head of Development at Albany Molecular Research, Inc. and … [Read more...] about Nanopharm adds to management team

Training device and patient onboarding company Noble International, which was acquired by Aptar Pharma in October 2019, has announced the appointment of Jeffrey Miller as Director, Business Development. The company manufactures training devices that mimic marketed MDIs and DPIs that can simulate actuation force and provide feedback for guiding and correcting … [Read more...] about Noble International names Jeffrey Miller as Director, Business Development

Vectura has announced the appointment of Sharon Johnson to the newly created position of Executive VP for Delivery Management "to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space." Johnson was most recently Senior VP, Global Quality and … [Read more...] about Vectura names Sharon Johnson as Executive VP for Delivery Management

Inhaled insulin developer Aerami Therapeutics (formerly Dance Biopharm) has announced the appointment of Timm Crowder as Chief Operating Officer. Crowder, who was most recently Chief Operating Officer of Spyryx Biosciences, was a co-founder of DPI developer Oriel Therapeutics. Following Oriel's acquisition by Sandoz in 2010, Crowder held a series of manufacturing … [Read more...] about Timm Crowder named Chief Operating Officer of Aerami Therapeutics

Verona Pharma has announced the appointment of former United Therapeutics executive David Zaccardelli as President and CEO, succeeding Jan-Anders Karlsson, who is retiring. Zaccardelli was most recently President and CEO of Dova Pharmaceuticals, which was acquired by Sobi in November 2019. The company also announced the appointment of Mark W. Hahn as Chief Financial … [Read more...] about Verona Pharma appoints David Zaccardelli as President and CEO